Bosch sets standards in sterile powder filling with AFG 5000
The system's new, variable transport system avoids bottlesnecks or delays in workflow.
This fall, pharmaceutical manufacturers can look forward to another innovation from Bosch Packaging Technology: from 18-29 September 2017, Bosch will showcase the new filling and closing machine AFG 5000 for the first time on the occasion of an exclusive machine presentation in Crailsheim, Germany.
With the AFG 5000, Bosch has developed a machine platform for the sterile filling of powders in glass vials with a wide range of versions. Depending on the features, both small and large amounts of powder can be dosed with high accuracy. Thanks to a varying number of filling stations, the AFG achieves outputs of up to 480 vials per minute.
The machine is equipped with a new, variable transport system. Its speed is precisely adapted to the rhythm of the individual stations such as filling, weighing and stopper insertion. This way, delays in the workflow can be avoided, and the vials are optimally timed – without any bottlenecks or idle times. Moreover, the lean and compact design of the AFG 5000 and its quick format changes save time, space and costs.
Related News
-
News Pharmaceutical Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain.
-
News Merck KGaA to buy US biotech SpringWorks for US$3.9 billion
The German multinational pharmaceutical company Merck KGaA have signed a deal to buy US biotech company SpringWorks Therapeutics at an equity value of US$3.9 billion in a move to add rare cancer therapeutics to their pipelines.
-
News Cassava Sciences halts Alzheimer's drug trial after limited progress
Cassava Sciences have drawn a close to their investigations and development of the drug simufilam, which they intended to be used for the treatment of Alzheimer’s disease.
-
News US FDA adds haemodialysis bloodlines to devices shortage list
On March 14, 2025, the US FDA published an open letter to healthcare providers citing continuing supply disruptions of haemodialysis bloodlines, an essential component of dialysis machines.
-
News Vertex Pharmaceuticals stock jumps as FDA approves non-opioid painkiller
UK-based Vertex Pharmaceuticals saw their stock shares soar as the US FDA signed off on the non-opioid painkiller Journavx, also known as suzetrigine, for patients with moderate to severe acute pain, caused by surgery, accidents, or injuries.
-
News Lessons from CPHI Milan 2024: Sunny Intervals for Pharma Manufacturing?
As the 2024 CPHI conference wrapped up in Milan, we caught up with L.E.K. Consulting – a global strategy consulting firm with deep expertise in pharma manufacturing – to discuss evolving market perspectives and business outlook. -
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement.